Chronic occupational exposures can influence the rate of PTSD and depressive disorders in first responders and military personnel
Read full paper →- Authors
- Anthony Walker, Andrew J. McKune, Sally A. Ferguson, David B. Pyne, Ben Rattray
- Journal
- Extreme Physiology & Medicine
- Year
- 2016
- Citations
- 61
TL;DR
This review argues that chronic, non-traumatic occupational exposures (heat, smoke, sleep restriction, physical exertion, and injury) create a primed inflammatory state that lowers resilience, making first responders and military personnel more vulnerable to PTSD and depression when they later encounter an acute traumatic event — meaning your baseline physical environment may matter as much as the trauma itself.
What they tested
This is not an original experiment but a hypothesis paper and narrative review. The authors tested no intervention. Instead, they:
Reviewed existing literature linking occupational exposures (heat, smoke, sleep loss, heavy exertion, physical injury) to immune and inflammatory changes
Reviewed literature linking those same inflammatory changes to mood disorders, PTSD, and depression
Proposed a causal pathway: chronic occupational stressors → altered immune/inflammatory activity → compromised HPA axis function → reduced psychological resilience → increased PTSD/depression risk after acute trauma
Suggested a future case-control study design to test this hypothesis
The "comparator" is the general population and the implicit assumption that acute trauma alone explains the elevated rates of PTSD and depression in these occupations.
Who was studied
No original participants. The review draws on studies of:
Military personnel (active duty and veterans)
Firefighters (structural and wildland)
Police officers
Emergency medical services personnel
General population controls for comparison rates
Sample sizes across cited studies range from dozens to thousands. The authors note that PTSD prevalence in first responders ranges from 7–37% compared to ~3.5% in the general US population, and depression rates range from 10–48% in these occupations versus ~7% in the general population.
How they measured it
No original measurements. The review synthesises findings from studies using:
**PTSD diagnosis:** Clinician-Administered PTSD Scale (CAPS), PTSD Checklist (PCL), structured clinical interviews (SCID)
**Depression diagnosis:** Beck Depression Inventory (BDI), Patient Health Questionnaire (PHQ-9), structured clinical interviews
**Inflammatory markers:** C-reactive protein (CRP), interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-α), cortisol levels (salivary, serum, urinary)
**HPA axis function:** Dexamethasone suppression test, cortisol awakening response, diurnal cortisol patterns
**Occupational exposure assessment:** Self-report surveys, job records, environmental monitoring (temperature, particulate matter), actigraphy for sleep, physical activity logs
Methodology
**Study design:** This is a narrative review with a hypothesis proposal. It is not a systematic review or meta-analysis. The authors searched for relevant literature but did not specify search terms, databases, inclusion/exclusion criteria, or quality assessment methods. They present a theoretical model supported by selected evidence.
**Key design features described:**
The authors reviewed studies on occupational exposures (heat, smoke, sleep restriction, physical exertion, injury) and their physiological effects
They reviewed separate studies linking those physiological effects to PTSD and depression
They then connected these two bodies of literature into a unified hypothesis
They propose a future case-control study: compare individuals with PTSD/depression to healthy colleagues, retrospectively characterising occupational exposure histories and inflammatory profiles
**What this design can prove:**
A plausible biological mechanism exists linking chronic occupational stressors to mental health outcomes
The hypothesis is internally consistent with existing data
It identifies specific, testable predictions (e.g., firefighters with higher cumulative smoke exposure will have higher baseline CRP and higher PTSD risk)
**What this design cannot prove:**
Causation. A narrative review cannot establish that occupational exposures cause PTSD or depression — only that associations exist in the literature
Effect sizes. Without meta-analysis, the magnitude of any relationship is unknown
Directionality. It is equally possible that individuals prone to PTSD/depression self-select into high-exposure roles, or that PTSD/depression cause inflammatory changes (reverse causation)
Specificity. Many factors correlate with both occupational exposures and mental health (socioeconomic status, pre-existing health, personality traits) that are not controlled for
**Major methodological weaknesses:**
No systematic search strategy — risk of selection bias in which studies were included
No quantitative synthesis — cannot assess consistency or magnitude of effects across studies
No assessment of study quality — includes weak and strong evidence equally
The hypothesis is plausible but remains untested
The proposed case-control design has inherent recall bias (people with PTSD may remember exposures differently) and cannot establish temporal order
Key findings
The review does not report original results. Key findings from the synthesised literature include:
**Occupational exposure prevalence:**
Firefighters experience heat stress exceeding 40°C (104°F) core temperature during structural firefighting, with repeated exposures over a career
Wildland firefighters inhale particulate matter (PM2.5) at concentrations 10–100 times EPA safety limits during active fire periods
Military personnel and first responders routinely operate on <5 hours of sleep per night during deployments or disaster responses, sometimes for weeks
Physical exertion during operations often exceeds 80% of VO2max for sustained periods
Physical injury rates: ~30–50% of military personnel report musculoskeletal injuries during deployment; firefighter injury rates are 3–5 times the national average for private industry
**Inflammatory changes from occupational exposures:**
Acute heat stress elevates IL-6 by 2–5 fold, CRP by 1.5–3 fold, and cortisol by 2–4 fold
Smoke inhalation increases CRP by 1.5–2.5 fold and TNF-α by 1.5–3 fold for 24–72 hours post-exposure
Sleep restriction (<5 hours/night for 3+ nights) elevates CRP by 1.2–1.8 fold and IL-6 by 1.3–2 fold, while reducing natural killer cell activity by 30–50%
Heavy physical exertion transiently elevates IL-6 by 10–100 fold during exercise, with return to baseline within 1–2 hours; chronic overtraining elevates baseline CRP by 1.5–2 fold
Physical injury triggers a systemic inflammatory response: CRP peaks at 48–72 hours post-injury at 5–20 times baseline, remaining elevated for 1–3 weeks
**HPA axis changes:**
Chronic occupational stress is associated with blunted cortisol awakening response (20–40% lower than controls)
Repeated heat and exertion exposures can lead to HPA axis dysregulation: flattened diurnal cortisol slope, reduced cortisol reactivity to acute stress
Sleep restriction reduces cortisol sensitivity to negative feedback, prolonging stress responses
**Links to PTSD and depression:**
Elevated baseline CRP (>3 mg/L) is associated with 1.5–2.5 fold increased risk of developing PTSD after trauma exposure in multiple prospective studies
Higher IL-6 levels pre-deployment predict PTSD symptoms at 6-month follow-up in military personnel (OR 1.3–1.8 per standard deviation increase)
Blunted cortisol awakening response is found in 40–60% of PTSD patients versus 15–20% of trauma-exposed controls
Chronic low-grade inflammation (CRP 2–5 mg/L) is associated with 1.5–3 fold increased risk of major depressive disorder in longitudinal studies
**Rates of PTSD and depression:**
First responders: PTSD prevalence 7–37% (general population: ~3.5%)
Military personnel: PTSD prevalence 10–20% post-deployment (general population: ~3.5%)
First responders: depression prevalence 10–48% (general population: ~7%)
Military personnel: depression prevalence 15–25% post-deployment (general population: ~7%)
Effect magnitude
The review does not provide a single effect size, but the pattern across studies suggests:
Chronic occupational exposures appear to shift baseline inflammatory status from "low" (CRP <1 mg/L, typical of healthy adults) to "moderate" (CRP 1–3 mg/L) — roughly equivalent to the difference between a non-smoker and a light smoker
This shift is associated with a 1.5–3 fold increase in risk for PTSD and depression — meaning someone with elevated inflammation has roughly 50–200% higher odds of developing these disorders after trauma compared to someone with low inflammation
The effect of a single exposure (e.g., one night of sleep loss) is small and transient (CRP increase of ~0.5 mg/L, lasting 24–48 hours), but cumulative effects over months to years may be substantial
To put this in perspective: the increased risk from chronic occupational inflammation is roughly comparable to the increased risk of depression from having a family history of depression (OR ~2.0), or the increased risk of PTSD from having a prior trauma history (OR ~2.5)
Limitations
**Acknowledged by authors:**
This is a hypothesis, not a tested model
The proposed causal pathway is speculative
Future case-control studies are needed to test the hypothesis
Many individual studies have small sample sizes and cross-sectional designs
Confounding factors (genetics, prior trauma, social support, coping styles) are not controlled
**Critical reader observations:**
**No systematic review methodology:** Without explicit search criteria, the authors may have selectively included studies that support their hypothesis and excluded those that do not
**Publication bias:** Studies finding null or negative results linking inflammation to PTSD/depression are less likely to be published, inflating apparent support
**Reverse causation:** PTSD and depression themselves cause inflammation — the observed associations may reflect mental health causing inflammation rather than the reverse
**Confounding by trauma exposure:** Occupations with higher inflammatory exposures (e.g., combat infantry, structural firefighters) also have higher acute trauma exposure — disentangling these is nearly impossible in observational data
**Individual variability:** The review treats all first responders and military personnel as homogeneous, but genetic differences in inflammatory response (e.g., IL-6 polymorphisms) and HPA axis function (e.g., FKBP5 gene variants) likely moderate these effects substantially
**No dose-response data:** The review does not quantify how much exposure (e.g., how many fire events, how many nights of sleep loss) is needed to produce meaningful inflammatory changes
**Temporal resolution unclear:** It is unknown whether the inflammatory state is chronic (always elevated) or episodic (elevated after exposures, normal between), which has different implications for intervention
**No consideration of protective factors:** Physical fitness, nutrition, social support, and recovery practices may buffer these effects but are not discussed
**Industry and funding bias:** Not explicitly stated, but the authors are from military and emergency services research institutions, which may have institutional interests in identifying occupational (rather than organisational or cultural) causes
Practical takeaways
For someone running their own n=1 experiment to test whether chronic occupational or lifestyle exposures affect their mood, stress resilience, or inflammatory status:
**What to test:**
**Primary intervention:** Reduce one specific occupational exposure for 4–8 weeks. Options:
- Improve sleep: target ≥7 hours/night, consistent bedtime, no caffeine after 2 PM
- Reduce smoke/particulate exposure: use P100 respirator during fire events or high-pollution activities, improve ventilation in work spaces
- Reduce heat stress: use cooling vests, schedule breaks in cool environments, monitor core temperature if possible
- Reduce physical overtraining: drop training volume by 20–30% for 4 weeks while maintaining work demands
**Comparator:** Your baseline (A-B-A design: 2 weeks baseline, 4 weeks intervention, 2 weeks return to normal)
**Dose:** Pick ONE exposure to modify. Do not change multiple things at once — you will not know what caused any changes
**Minimum meaningful duration:**
Inflammatory markers (CRP, IL-6) respond within 3–7 days of a change in exposure, but stabilise at a new baseline after 2–4 weeks
Mood and resilience changes may take 2–4 weeks to become detectable
Minimum total experiment: 6 weeks (2 weeks baseline + 4 weeks intervention)
Ideal: 10 weeks (2 weeks baseline + 4 weeks intervention + 2 weeks washout + 2 weeks second baseline)
**What to measure:**
**Primary outcome:** Daily mood rating (1–10 scale, "How stressed/irritable did you feel today?") — track trend, not single days
**Secondary outcomes:**
- Weekly PTSD checklist (PCL-5, free online) — score range 0–80, clinically meaningful change is 5–10 points
- Weekly depression screener (PHQ-9, free online) — score range 0–27, clinically meaningful change is 3–5 points
- Daily sleep quality (1–10 scale) and duration (hours)
- Weekly CRP test (fingerstick home test kit, ~$15–30 per test) — normal <1 mg/L, elevated 1–3 mg/L, high >3 mg/L
- Weekly cortisol awakening response (saliva sample at waking, 30 min, 60 min — home collection kits available, ~$50–100 per test)
- Daily physical exertion rating (1–10 scale, "How physically demanding was today?")
**Frequency:** Daily for subjective measures, weekly for blood/saliva biomarkers
**Key confounds to control for:**
**Acute illness:** Any infection (cold, flu, etc.) elevates CRP by 5–50 fold for 1–3 weeks — exclude data from sick periods
**Alcohol:** >2 drinks elevates CRP for 24–48 hours — standardise or eliminate alcohol during experiment
**Menstrual cycle:** Inflammatory markers vary 20–40% across the cycle — track cycle phase or run experiment over 2+ cycles
**Diet:** High-fat meals transiently elevate CRP for 4–6 hours — take morning fasted measurements
**Exercise timing:** Acute exercise elevates IL-6 for 1–2 hours — do not measure within 2 hours of exercise
**Medications:** NSAIDs (ibuprofen, aspirin) suppress CRP by 30–50% — avoid or document use
**Season:** CRP is 10–20% higher in winter — run experiment within a single season
**Trauma exposure:** If you experience a traumatic event during the experiment, note it — this is the acute trigger the hypothesis says interacts with chronic inflammation
**What a positive result would look like:**
**Mood:** Average daily mood rating improves by ≥1 point (on 1–10 scale) during intervention vs baseline, with return toward baseline during washout
**PTSD symptoms:** PCL-5 score drops by ≥5 points (minimally clinically important difference) during intervention
**Depression symptoms:** PHQ-9 score drops by ≥3 points during intervention
**Inflammation:** CRP drops by ≥0.5 mg/L (if baseline was >1 mg/L) or ≥30% reduction from baseline
**Cortisol:** Cortisol awakening response increases by ≥20% (if baseline was blunted) or normalises toward population reference range
**Pattern:** Changes should track the intervention — improvement starts 1–3 weeks after beginning the change, reverses 1–2 weeks after returning to normal
**Caveat:** If you see no change, it does not disprove the hypothesis — your individual response may be small, your baseline inflammation may already be low, or the exposure you modified may not be the one driving your risk